CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 696 of 865
Non-Antibody Products
Page 696 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| RBC8 | An inhibitor of the Ras-like GTPases RalA and RalB; prevents spreading of… | 1 mg | 21281-1 | More Info |
| RBC8 | An inhibitor of the Ras-like GTPases RalA and RalB; prevents spreading of… | 10 mg | 21281-10 | More Info |
| RBC8 | An inhibitor of the Ras-like GTPases RalA and RalB; prevents spreading of… | 25 mg | 21281-25 | More Info |
| RBC8 | An inhibitor of the Ras-like GTPases RalA and RalB; prevents spreading of… | 5 mg | 21281-5 | More Info |
| (R)-benzyl Mandelate | A synthetic intermediate useful for pharmaceutical synthesis. | 1 g | 10007145-1 | More Info |
| (R)-benzyl Mandelate | A synthetic intermediate useful for pharmaceutical synthesis. | 10 g | 10007145-10 | More Info |
| (R)-benzyl Mandelate | A synthetic intermediate useful for pharmaceutical synthesis. | 5 g | 10007145-5 | More Info |
| (R)-benzyl Mandelate | A synthetic intermediate useful for pharmaceutical synthesis. | 50 g | 10007145-50 | More Info |
| RBI 257 (maleate) | A potent dopamine D4 receptor antagonist (Ki = 0.3 nM) that is selective o… | 1 mg | 17223-1 | More Info |
| RBI 257 (maleate) | A potent dopamine D4 receptor antagonist (Ki = 0.3 nM) that is selective o… | 10 mg | 17223-10 | More Info |
| RBI 257 (maleate) | A potent dopamine D4 receptor antagonist (Ki = 0.3 nM) that is selective o… | 5 mg | 17223-5 | More Info |
| Rbin-1 | An inhibitor of midasin; inhibits the growth of fission yeast strains in v… | 1 mg | 20745-1 | More Info |
| Rbin-1 | An inhibitor of midasin; inhibits the growth of fission yeast strains in v… | 5 mg | 20745-5 | More Info |
| RBN-012759 | A PARP14 inhibitor (IC50 = 0.003 µM); selective for PARP14 over PARP… | 1 mg | 36137-1 | More Info |
| RBN-012759 | A PARP14 inhibitor (IC50 = 0.003 µM); selective for PARP14 over PARP… | 10 mg | 36137-10 | More Info |
| RBN-012759 | A PARP14 inhibitor (IC50 = 0.003 µM); selective for PARP14 over PARP… | 25 mg | 36137-25 | More Info |
| RBN-012759 | A PARP14 inhibitor (IC50 = 0.003 µM); selective for PARP14 over PARP… | 5 mg | 36137-5 | More Info |
| RBN-2397 | A PARP7 inhibitor; stabilizes wild-type PARP7 levels, but not levels of th… | 1 mg | 33558-1 | More Info |
| RBN-2397 | A PARP7 inhibitor; stabilizes wild-type PARP7 levels, but not levels of th… | 10 mg | 33558-10 | More Info |
| RBN-2397 | A PARP7 inhibitor; stabilizes wild-type PARP7 levels, but not levels of th… | 5 mg | 33558-5 | More Info |
| (R)-Bromoenol lactone | A selective iPLA2γ inhibitor (IC50 = ~0.6 µM); selective for i… | 1 mg | 10006800-1 | More Info |
| (R)-Bromoenol lactone | A selective iPLA2γ inhibitor (IC50 = ~0.6 µM); selective for i… | 10 mg | 10006800-10 | More Info |
| (R)-Bromoenol lactone | A selective iPLA2γ inhibitor (IC50 = ~0.6 µM); selective for i… | 5 mg | 10006800-5 | More Info |
| (R)-Bromoenol lactone | A selective iPLA2γ inhibitor (IC50 = ~0.6 µM); selective for i… | 500 µg | 10006800-500 | More Info |
| (R)-Bromoenol lactone-d7 | An internal standard for the quantification of (R)-BEL by GC- or LC-MS | 1 mg | 10534-1 | More Info |
| (R)-Bromoenol lactone-d7 | An internal standard for the quantification of (R)-BEL by GC- or LC-MS | 100 µg | 10534-100 | More Info |
| (R)-Bromoenol lactone-d7 | An internal standard for the quantification of (R)-BEL by GC- or LC-MS | 500 µg | 10534-500 | More Info |
| (R)-(4-Bromophenyl)(phenyl)methanamine | A synthetic intermediate; has been used in the synthesis of δ-opioid… | 100 mg | 37310-100 | More Info |
| (R)-(4-Bromophenyl)(phenyl)methanamine | A synthetic intermediate; has been used in the synthesis of δ-opioid… | 25 mg | 37310-25 | More Info |
| (R)-(4-Bromophenyl)(phenyl)methanamine | A synthetic intermediate; has been used in the synthesis of δ-opioid… | 50 mg | 37310-50 | More Info |
| (R)-Butaprost | Butaprost is a structural analog of PGE2 with good selectivity for the EP2… | 1 mg | 13745-1 | More Info |
| (R)-Butaprost | Butaprost is a structural analog of PGE2 with good selectivity for the EP2… | 10 mg | 13745-10 | More Info |
| (R)-Butaprost | Butaprost is a structural analog of PGE2 with good selectivity for the EP2… | 5 mg | 13745-5 | More Info |
| (R)-Butaprost (free acid) | A C-16 epimer of butaprost, a selective EP2 receptor agonist | 1 mg | 10006045-1 | More Info |
| (R)-Butaprost (free acid) | A C-16 epimer of butaprost, a selective EP2 receptor agonist | 10 mg | 10006045-10 | More Info |
| (R)-Butaprost (free acid) | A C-16 epimer of butaprost, a selective EP2 receptor agonist | 5 mg | 10006045-5 | More Info |
| (R)-Butaprost (free acid) | A C-16 epimer of butaprost, a selective EP2 receptor agonist | 500 µg | 10006045-500 | More Info |
| RC363 | An inhibitor of ferroptosis; reduces DPPH radicals by ~40% in a cell-free… | 1 mg | 31407-1 | More Info |
| RC363 | An inhibitor of ferroptosis; reduces DPPH radicals by ~40% in a cell-free… | 10 mg | 31407-10 | More Info |
| RC363 | An inhibitor of ferroptosis; reduces DPPH radicals by ~40% in a cell-free… | 5 mg | 31407-5 | More Info |
| RC574 | An inhibitor of ferroptosis; inhibits glutamate-induced cell death in HT22… | 1 mg | 31408-1 | More Info |
| RC574 | An inhibitor of ferroptosis; inhibits glutamate-induced cell death in HT22… | 10 mg | 31408-10 | More Info |
| RC574 | An inhibitor of ferroptosis; inhibits glutamate-induced cell death in HT22… | 5 mg | 31408-5 | More Info |
| (1R)-(+)-Camphor | A terpene with diverse biological activities; it inhibits DMPP-induced nor… | 100 mg | 23175-100 | More Info |
| (1R)-(+)-Camphor | A terpene with diverse biological activities; it inhibits DMPP-induced nor… | 500 mg | 23175-500 | More Info |
| RCB-4-8 | An ionizable cationic lipid; RCB-4-8-containing LNPs improve lung transfec… | 10 mg | 38803-10 | More Info |
| RCB-4-8 | An ionizable cationic lipid; RCB-4-8-containing LNPs improve lung transfec… | 25 mg | 38803-25 | More Info |
| RCB-4-8 | An ionizable cationic lipid; RCB-4-8-containing LNPs improve lung transfec… | 5 mg | 38803-5 | More Info |
| (R)-CCG-1423 | A stereoisomer of CCG-1423 that less potently inhibits MRTF-A-dependent ce… | 1 mg | 20106-1 | More Info |
| (R)-CCG-1423 | A stereoisomer of CCG-1423 that less potently inhibits MRTF-A-dependent ce… | 100 µg | 20106-100 | More Info |
| (R)-CCG-1423 | A stereoisomer of CCG-1423 that less potently inhibits MRTF-A-dependent ce… | 500 µg | 20106-500 | More Info |
| (R)-Cetirizine (hydrochloride) | A selective histamine H1 receptor antagonist; the (R)-enantiomer of cetiri… | 10 mg | 23992-10 | More Info |
| (R)-Cetirizine (hydrochloride) | A selective histamine H1 receptor antagonist; the (R)-enantiomer of cetiri… | 100 mg | 23992-100 | More Info |
| (R)-Cetirizine (hydrochloride) | A selective histamine H1 receptor antagonist; the (R)-enantiomer of cetiri… | 250 mg | 23992-250 | More Info |
| (R)-Cetirizine (hydrochloride) | A selective histamine H1 receptor antagonist; the (R)-enantiomer of cetiri… | 50 mg | 23992-50 | More Info |
| RCGD 423 | A gp130 modulator; increases levels of phosphorylated STAT3 and Myc in iso… | 1 mg | 31420-1 | More Info |
| RCGD 423 | A gp130 modulator; increases levels of phosphorylated STAT3 and Myc in iso… | 10 mg | 31420-10 | More Info |
| RCGD 423 | A gp130 modulator; increases levels of phosphorylated STAT3 and Myc in iso… | 25 mg | 31420-25 | More Info |
| RCGD 423 | A gp130 modulator; increases levels of phosphorylated STAT3 and Myc in iso… | 5 mg | 31420-5 | More Info |
| (R)-CPP | An NMDA receptor antagonist (Ki = 0.14 µM); binds to NMDA receptors… | 1 mg | 21569-1 | More Info |
| (R)-CPP | An NMDA receptor antagonist (Ki = 0.14 µM); binds to NMDA receptors… | 10 mg | 21569-10 | More Info |
| (R)-CPP | An NMDA receptor antagonist (Ki = 0.14 µM); binds to NMDA receptors… | 25 mg | 21569-25 | More Info |
| (R)-CPP | An NMDA receptor antagonist (Ki = 0.14 µM); binds to NMDA receptors… | 5 mg | 21569-5 | More Info |
| (R)-CR8 | A second-generation analog of (R)-roscovitine that inhibits Cdk1, 2, 5, an… | 1 mg | 14006-1 | More Info |
| (R)-CR8 | A second-generation analog of (R)-roscovitine that inhibits Cdk1, 2, 5, an… | 10 mg | 14006-10 | More Info |
| (R)-CR8 | A second-generation analog of (R)-roscovitine that inhibits Cdk1, 2, 5, an… | 5 mg | 14006-5 | More Info |
| (R)-Crizotinib | A dual inhibitor of c-Met and ALK (IC50s = 8 and 20 nM, respectively, in a… | 100 mg | 12087-100 | More Info |
| (R)-Crizotinib | A dual inhibitor of c-Met and ALK (IC50s = 8 and 20 nM, respectively, in a… | 250 mg | 12087-250 | More Info |
| (R)-Crizotinib | A dual inhibitor of c-Met and ALK (IC50s = 8 and 20 nM, respectively, in a… | 50 mg | 12087-50 | More Info |
| (R)-Crizotinib | A dual inhibitor of c-Met and ALK (IC50s = 8 and 20 nM, respectively, in a… | 500 mg | 12087-500 | More Info |
| (R)-Crizotinib-d5 | An internal standard for the quantification of (R)-crizotinib by GC- or LC… | 1 mg | 26762-1 | More Info |
| (R)-Crizotinib-d5 | An internal standard for the quantification of (R)-crizotinib by GC- or LC… | 500 µg | 26762-500 | More Info |
| RCS-4 | An analytical reference standard structurally similar to known synthetic c… | 1 mg | 10645-1 | More Info |
| RCS-4 | An analytical reference standard structurally similar to known synthetic c… | 10 mg | 10645-10 | More Info |
| RCS-4 | An analytical reference standard structurally similar to known synthetic c… | 5 mg | 10645-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile